|Articles|August 25, 2015
Bill to Modernize FDA Communication
U.S. Representative Billy Long has introduced legislation to update regulations guiding how drug manufacturers communicate product information.
Advertisement
U.S. Representative Billy Long (R-MO 7th District) has introduced legislation to update regulations guiding how drug manufacturers communicate product information. Long is the lead sponsor of H.R. 2479, which would ensure the FDA clearly regulated meaningful, truthful and non-misleading communication of product information on social media.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5